Publications Office of the EU
Antineoplastic and endocrinological agents (L01-L02) - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates CPV codes deduced from the text of the procedure

- indicates text translated automatically in your browsing language

Antineoplastic and endocrinological agents (L01-L02) Text automatically translated in your browsing language Automatically translated

  • Published
    20/01/2025
  • Deadline
    17/02/2025
  • Opening of tenders
    17/02/2025
  • Today
    20/03/2025
Status
Submission closed
Type of contract
Supplies
Subject for Renewal
No
Buyer
Aktsiaselts Ida-Tallinna Keskhaigla
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: Not available
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
12,398,000.00 EUR
Total final contract value (excluding VAT)
Not available
Number of lots
39
Tender reference number
289398
Description

Purchase of medicinal products as described in Annex I to the RHAD Technical Specifications-Tender Form. Text automatically translated in your browsing language Automatically translated

Submission Method
Electronic via:
https://riigihanked.riik.ee/rhr-web/#/procurement/8312364/tenders
Tenders may be submitted
Electronic submission: required
https://riigihanked.riik.ee/rhr-web/#/procurement/8312364/tenders
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
The procurement involves the establishment of a framework agreement
Conditions for opening tenders (date)
17/02/2025 12:00
CPV code
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.